Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Inhibitors of ceramide de novo biosynthesis rescue damages induced by cigarette smoke in airways epithelia
These stories provide proof that safe, science-backed treatment leads to real results
The American Diabetes Associations position that metformin should remain the first-line treatment for most type 2 diabetes cases is partly driven by this cost advantage at roughly $120 per year versus over $11,000 annually for Rybelsus, metformins modest efficacy is justified for 90% of people starting type 2 diabetes treatment
Failure to identify the responsible drug can lead to significant delays in treatment, potentially resulting in critical outcomes (Jones et al., 2015)
Pharmacological activation of Nrf2 enhances the expression of cytoprotective genes, conferring resistance against oxidative injury and fibrogenesis in DKD models (242)
